STAT3 and osteosarcoma: While multidrug-resistant osteosarcoma cell lines exhibit a constitutive activated Stat3 pathway with elevated levels of p-STAT3, treatment with bardoxolone methyl inhibited cell growth and induced apoptosis in osteosarcoma cells, significantly reducing the nuclear translocation and p-STAT3.